Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biosig Technologies (BSGM)

Biosig Technologies (BSGM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 145,280
  • Shares Outstanding, K 31,790
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,220 K
  • 60-Month Beta 1.79
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.58
Trade BSGM with:

Options Overview

Details
  • Implied Volatility 90.29%
  • Historical Volatility 69.70%
  • IV Percentile 3%
  • IV Rank 14.20%
  • IV High 219.26% on 08/14/20
  • IV Low 68.94% on 04/09/21
  • Put/Call Vol Ratio 0.19
  • Today's Volume 86
  • Volume Avg (30-Day) 274
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 12,229
  • Open Int (30-Day) 5,221

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.00 +5.25%
on 03/25/21
5.10 -17.45%
on 03/18/21
-0.37 (-8.08%)
since 03/12/21
3-Month
3.81 +10.50%
on 03/05/21
5.77 -27.04%
on 02/11/21
-1.07 (-20.27%)
since 01/14/21
52-Week
2.79 +50.90%
on 10/27/20
12.43 -66.13%
on 05/12/20
-0.81 (-16.14%)
since 04/14/20

Most Recent Stories

More News
BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform

The latest release represents the most advanced software version of the PURE EP System, signal processing technology for treatments of irregular heartbeats

BSGM : 4.21 (-2.55%)
BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study

EQNX::TICKER_START (NASDAQ:BSGM), EQNX::TICKER_END

BSGM : 4.21 (-2.55%)
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)

EQNX::TICKER_START (NASDAQ:BSGM), EQNX::TICKER_END

BSGM : 4.21 (-2.55%)
AMZN : 3,333.00 (-1.97%)
BAYN : 0.0100 (unch)
GE : 13.68 (+1.79%)
GSK : 36.13 (+0.25%)
EP Lab Digest Features Physician Experience with BioSig's Cardiac Signal Acquisition Technology

EQNX::TICKER_START (NASDAQ:BSGM), EQNX::TICKER_END

BSGM : 4.21 (-2.55%)
BioSig lands Commercial Sales to Leading Hospital System

EQNX::TICKER_START (NASDAQ:BSGM), EQNX::TICKER_END

BSGM : 4.21 (-2.55%)
BioSig Technologies, Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference

BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover...

BSGM : 4.21 (-2.55%)
BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing Technology

EQNX::TICKER_START (NASDAQ:BSGM), EQNX::TICKER_END

BSGM : 4.21 (-2.55%)
BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021

EQNX::TICKER_START (NASDAQ:BSGM), EQNX::TICKER_END

BSGM : 4.21 (-2.55%)
BioSig CEO Kenneth L. Londoner to Present at the Benzinga Biotech Small Cap Conference

BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover...

BSGM : 4.21 (-2.55%)
BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare Conference

BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover...

BSGM : 4.21 (-2.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The Company's first product, PURE EP (tm) System, is a computerized system intended...

See More

Key Turning Points

3rd Resistance Point 4.69
2nd Resistance Point 4.59
1st Resistance Point 4.40
Last Price 4.21
1st Support Level 4.11
2nd Support Level 4.01
3rd Support Level 3.82

See More

52-Week High 12.43
Fibonacci 61.8% 8.75
Fibonacci 50% 7.61
Fibonacci 38.2% 6.47
Last Price 4.21
52-Week Low 2.79

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar